In conclusion, in the present work we have demonstrated that in subjects with severe HF with reduced ejection fraction, treatment with SGLT-2i is associated with reduced inflammation and pro-inflammatory immune cell infiltration and an anti-inflammatory and anti-ferroptotic shift in the lipid spectr...